Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines

SANTA CLARA, Calif., January 25, 2021  Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm. The latest revision of these software enables data integrity consistent with the regulatory requirements from the US FDA and EU EMEA guidance, providing user management, checksums, tamper detection,... Read more

Roche renews partnership with Sysmex to deliver haematology testing solutions

This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of... Read more

Roche’s faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration

Faricimab given at intervals of up to every 16 weeks demonstrated non-inferior visual acuity gains compared to aflibercept given every eight weeks, potentially reducing the frequency of injections and overall burden of treatment Nearly half of people were treated with faricimab every 16 weeks during the first year – the first time this level of... Read more

HORIBA FRANCE opens a new R&D and production site

01/22/2021 |   News On January 4, 2021, HORIBA FRANCE SAS, the world leader in Raman spectroscopy, inaugurated its new site in Loos, Hauts-de-France. Formerly located in Villeneuve d’Ascq, this production and R&D site will enable the company to meet the increasing demand for Raman spectroscopy and now its flagship product, LabRAM Soleil™, which was commercially launched in... Read more

Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

Jan 21, 2021 SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company has received the CE-IVD mark for its Advanta™ Dx SARS-CoV-2 RT-PCR Assay, an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.... Read more

A Look Inside the Microscopic World of Gems

An interview with a gemologist and microscope enthusiast Microscopist and photomicrographer, Nathan Renfro with his vintage blue ZEISS Universal microscope equipped for episcopic differential interference contrast. Photo by Holly Renfro Using a ZEISS microscope he built mainly from used parts he acquired over the years, Nathan Renfro has created a beautiful gallery of microscope images... Read more

SCIEX Acquires Intabio, a developer of precision solutions for biotherapeutic analysis through imaged cIEF-MS

Innovative charged variant analysis accelerates biologic drug development, ensuring drug safety and efficacyJanuary 21, 2021 12:00 PM Eastern Standard Time FRAMINGHAM, Mass.–(BUSINESS WIRE)–SCIEX, a global leader in life science analytical technologies, announced the closing of its acquisition of Intabio, Inc., a privately held company and the developer of the Blaze™ System for biotherapeutic analysis and quality... Read more

Dynamic Transformation between Covalent Organic Frameworks and Discrete Organic Cages

   From The Journal: JACS   Abstract We propose a dynamic covalent chemistry (DCC)-induced linker exchange strategy for the structural transformation between covalent organic frameworks (COFs) and cages for the first time. Studies have shown that the COF-to-cage and cage-to-COF transformations were realized by using borate bonds and imine bonds, respectively, as linkages. Self-sorting experiments... Read more

Sales of Novel Coronavirus PCR Testing Reagent Kits outside Japan Exports Began

January 21, 2021 Shimadzu Corporation will begin fully rolling out sales of the novel coronavirus (SARS-CoV-2) detection reagent kits outside Japan. On January 19th, Shimadzu obtained provisional authorization from the Singapore Health Sciences Authority (HSA) to sell the kits and will start exporting the kits to Southeast Asian markets through Shimadzu (Asia Pacific) Pte. Ltd.,... Read more